9-Marie-Francoise Ritz MS

Total Page:16

File Type:pdf, Size:1020Kb

9-Marie-Francoise Ritz MS Send Orders for Reprints to [email protected] 478 Current Neurovascular Research, 2019, 16, 478-490 RESEARCH ARTICLE Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) Marie-Françoise Ritz1,*, Paul Jenoe2, Leo Bonati3, Stefan Engelter3,4, Philippe Lyrer3 and Nils Peters3,4 1Department of Biomedicine, Brain Tumor Biology Laboratory, University of Basel, and University Hospital of Basel, Hebelstrasse 20, 4031 Basel, Switzerland; 2Proteomics Core Facility, Biocenter, University of Basel, Klingelbergstrasse 50/70, 4056 Basel, Switzerland; 3Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Petersgraben 4, 4031 Basel, Switzerland; 4Neurorehabilitation Unit, University of Basel and University Center for Medicine of Aging, Felix Platter Hospital, Burgfelderstrasse 101, 4055 Basel, Switzerland Abstract: Background: Cerebral small vessel disease (SVD) is an important cause of stroke and vascular cognitive impairment (VCI), leading to subcortical ischemic vascular dementia. As a he- reditary form of SVD with early onset, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) represents a pure form of SVD and may thus serve as a model disease for SVD. To date, underlying molecular mechanisms linking vascular pathol- ogy and subsequent neuronal damage in SVD are incompletely understood. A R T I C L E H I S T O R Y Objective: We performed comparative transcriptional profiling microarray and proteomic analyses Received: October 01, 2019 on post-mortem frontal lobe specimen from 2 CADASIL patients and 5 non neurologically dis- Revised: October 11, 2019 Accepted: October 15, 2019 eased controls in order to identify dysregulated pathways potentially involved in the development DOI: of tissue damage in CADASIL. 10.2174/1567202616666191023111059 Methods: Transcriptional microarray analysis of material extracted from frontal grey and white matter (WM) identified subsets of up- or down-regulated genes enriched into biological pathways mostly in WM areas. Proteomic analysis of these regions also highlighted cellular processes identi- fied by dysregulated proteins. Results: Discrepancies between proteomic and transcriptomic data were observed, but a number of pathways were commonly associated with genes and corresponding proteins, such as: “ribosome” identified by upregulated genes and proteins in frontal cortex or “spliceosome” associated with down-regulated genes and proteins in frontal WM. Conclusion: This latter finding suggests that defective expression of spliceosomal components may alter widespread splicing profile, potentially inducing expression abnormalities that could contribute to cerebral WM damage in CADASIL. Keywords: CADASIL, transcriptomic, proteomic, pathomechanisms, spliceosome, ribosome. 1. INTRODUCTION dominant arteriopathy with subcortical infarcts and leukoen- cephalopathy (CADASIL) is the most common hereditary Small vessel disease (SVD) of the brain is a common form of SVD [2], caused by mutations in NOTCH3 gene on condition responsible for approximately 25% of all strokes chromosome 19q12, which encodes a transmembrane recep- and 40% of vascular dementia [1]. Cerebral autosomal tor playing a crucial role within vascular smooth muscle and pericyte signaling pathway [3]. Clinical manifestations ap- pearing in mid adulthood (between 30 and 40 years of age) *Address correspondence to this author at the University of Basel and comprise migraine with aura, lacunar stroke and vascular University Hospital of Basel, Department of Biomedicine, Brain Tumor cognitive impairment. Upon MR-imaging, the disease is Biology Laboratory, Hebelstrasse 20, 4031 Basel, Switzerland; E-mail: [email protected] characterized by typical SVD related lesions including dif- 1567-2026/19 $58.00+.00 © 2019 Bentham Science Publishers Transcriptomic and Proteomic Analyses of CADASIL Brains Current Neurovascular Research, 2019, Vol. 16, No. 5 479 fuse ischemic white matter lesions (WML), lacunar infarcts logical disease - in particular sporadic SVD, CADASIL or and microbleeds and eventually brain atrophy [4-6]. neurodegenerative diseases - were obtained from the Insti- tute of Pathology, University Hospital Basel and were used The extracellular domain of the mutated Notch3 receptor as healthy controls (72 ± 15 years, M/F: 4/1). The use of accumulates in the membrane of blood vessels, most likely postmortem material from deceased human subjects as con- leading to a progressive loss of vascular small muscle cells trols was approved by the local Ethics committee (EKBB, (VSMCs), thickening and stenosis of vessel walls by various Basel, Switzerland). Times to autopsy were <24 h post- types of collagens, laminins, and fibronectins, as well as de- mortem for all subjects. There was no significant difference posits of granular osmiophilic material (GOM) [7, 8] and in age between CADASIL and control groups (p=0.204, t- von Willebrand factor [9]. test). Tissue blocks dissected during autopsy were shock To date, the underlying molecular mechanisms linking frozen at -80°C until mRNA or protein extraction. vascular pathology in SVD and subsequent neuronal damage are incompletely understood. Various mechanisms have been 2.2. RNA Preparation and Microarray Processing discussed, including endothelial dysfunction, inflammatory The frozen brain samples were homogenized in Purezol processes, hemostasis, oxidative stress, disturbance of capil- solution (Bio-Rad Laboratories, Hercules, CA, USA) using a lary flow and altered function of the blood-brain-barrier [10, bead type-homogenizer (MM-301, Retsch, Haan, Germany). 11]. We recently studied the transcriptome profiles in post- Isolation of total RNA from the lysate including DNAse I mortem brains affected by sporadic SVD in comparison to treatment was carried out using the Aurum Total RNA Fatty normal brains in order to gain insight in the pathogenesis and Fibrous Tissue kit (BioRad Laboratories) according to [12]. We found regional alterations in gene expression in- the manufacturer’s protocol. The purity and integrity of the volving various pathways, such as inflammation, apoptosis, extracted total RNA were determined using the Agilent 2100 and alterations in lipid metabolism and coagulation. How- Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). ever, given the age association of sporadic SVD, there are All RNA samples had an integrity number > 7. Double potentially confounding alterations present, such as concomi- strand cDNA and labeled cRNA were prepared as previously tant neurodegeneration, having a possible influence on the published [14] and 12 µg fragmented cRNA was used for observed findings. As a hereditary condition with earlier hybridization to the Affymetrix GeneChip® Human Gene 1.0 onset, CADASIL can be regarded as a pure form of SVD, ST Arrays (Affymetrix, Santa Clara, CA, USA). Sample potentially allowing to study the underlying mechanisms of labeling, hybridization, scanning and data outputs were per- SVD in more detail. Therefore, in this study, a similar whole formed according to Affymetrix protocol. Data expression genome analysis was performed in CADASIL brains com- values were collected as individual CEL files. bined with a proteomic approach, in order to identify the correspondence of transcriptional responses to cellular pro- 2.3. Analysis of Gene Expression Data tein abundance. Indeed, proteins are effectors of biological ® function and their levels are not only dependent on mRNA Microarray data were normalized using Partek Genom- TM levels but also on host translational control and regulation ics Suite version 6.6 (Partek Inc., St. Louis, MO, USA). [13]. Thus, the proteomics should be considered as the most Data analysis including background subtraction, normaliza- relevant data set to characterize a biological system. tion, and elimination of false positives was performed using the default parameters. The principal component analysis The outcome of such an analysis is thought to offer a (PCA) was performed to assess the variation in the expres- comprehensive view of the biological roles of the selected sion of genes among the different samples. The unsupervised genes/proteins through highlighting key pathways and cellu- gene hierarchical clustering containing all the genes differ- lar processes in which they are involved. ently expressed between the two groups was used to estimate similarities in expression patterns between samples. One- Focusing on the changes of expression of genes and pro- teins in the frontal lobe, this work identified deregulation of way analysis of variance (ANOVA) was used to identify the spliceosome, which could produce splicing abnormalities genes differentially expressed between CADASIL and con- leading to generalized protein disbalance. This finding repre- trol samples for each brain region. Criteria for significant sents a yet unsuspected molecular dysfunction in cerebral changes in signal levels were: False Discovery Rate (FDR) small vessel diseases that needs to be further investigated. value < 0.05, and a fold change F (log transformed base 2.0) ≥ 1.2 in both directions. 2. MATERIALS AND METHODS 2.4. Proteomic Analysis 2.1. Human Brain Samples 2.4.1. Protein and Peptide Preparation The use of material from human patients was approved Biopsies
Recommended publications
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Overexpressed Nup88 Stabilized Through Interaction with Nup62 Promotes NFB
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.27.063057; this version posted May 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Overexpressed Nup88 stabilized through interaction with Nup62 promotes NFB dependent pathways in cancer Usha Singh1, Atul Samaiya2, and Ram Kumar Mishra1,* 1 Nups and Sumo Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Madhya Pradesh, 462066, India. 2 Department of Surgical Oncology, Bansal Hospital, Bhopal, Madhya Pradesh, 462016, India * To whom correspondence should be addressed. Corresponding Author: Phone – +91-755-2691407 Fax - +91-755-2692392 Email- [email protected] Keywords Nup88; NFB; Head and neck cancer; ubiquitination; cell proliferation; inflammation 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.27.063057; this version posted May 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Nuclear pores control nucleo-cytoplasmic trafficking and directly or indirectly regulate vital cellular processes. Nup88, important for Crm1 mediated nuclear export process, is overexpressed in many cancers. A positive correlation exists between progressive stages of cancer and Nup88 expression. However, links between Nup88 overexpression and head and neck cancer are insignificant, and mechanistic details are non-existent. Here, we report that Nup88 exhibits positive correlation in head and neck cancer in addition to elevated Nup62 levels. We demonstrate that Nup88 interacts with Nup62 in a cell-cycle and glycosylation independent manner.
    [Show full text]
  • Supplementary Table 3
    Supplemental Table 1 M e13 ∆∆Ct e13 M e15 ∆∆Ct e15 chromogranin A -3,26 (9,6 ↓ ) -6,29 (78 ↓ ) -2,56 (5,9 ↓ ) -6,57 (95 ↓ ) crystallin, beta A2 -0,95 (1,9 ↓ ) -4,57 (24 ↓ ) -1,82 (3,5 ↓ ) -4 (16 ↓ ) cyclin-dependent kinase inhibitor 1A (P21) -1,15 (2,2 ↓ ) -1,41 (2,7 ↓ ) -0,36 (1,3 ↓ ) 0,29 (1,2 ↑ ) cytochrome P450, family 4, subfamily b, polypeptide 1 -0,68 (1,6 ↓ ) 0,16 (1,1 ↑ ) -0,56 (1,5 ↓ ) -0,08 (1,1 ↓ ) myelin transcription factor 1 -1,28 (2,4 ↓ ) -2,62 (6,1 ↓ ) -1,46 (2,8 ↓ ) -3,59 (12 ↓ ) neurogenic differentiation 2 -0,06 (1,0 → ) NA -1,34 (2,5 ↓ ) NA neuronatin 0,14 (1,1 ↑ ) 0,12 (1,1 ↑ ) -0,79 (1,7 ↓ ) -2,02 (4,1 ↓ ) protocadherin 21 -1,62 (3,1 ↓ ) -5,71 (52 ↓ ) -1,77 (3,4 ↓ ) -6,41 (85 ↓ ) regulated endocrine-specific protein 18 -2,1 (4,3 ↓ ) -4,73 (27 ↓ ) -1,55 (2,9 ↓ ) -5,09 (34 ↓ ) retinol binding protein 4, plasma -1,68 (3,2 ↓ ) -1,52 (2,9 ↓ ) -1,53 (2,9 ↓ ) -2,15 (4,4 ↓ ) rhomboid, veinlet-like 4 (Drosophila) -1,14 (2,2 ↓ ) -0,29 (1,2 ↓ ) -1,09 (2,1 ↓ ) -0,58 (1,5 ↓ ) sestrin 2 -0,78 (1,7 ↓ ) -0,84 (1,8 ↓ ) -0,67 (1,6 ↓ ) -0,61 (1,5 ↓ ) synaptotagmin 13 -1,63 (3,1 ↓ ) -2,59 (6,0 ↓ ) -1,77 (3,4 ↓ ) -2,71 (6,5 ↓ ) t-complex protein 11 -0,48 (1,4 ↓ ) -1,35 (2,5 ↓ ) -0,68 (1,6 ↓ ) -2,83 (7,1 ↓ ) -0,62 (1,5 ↓ ) -0,76 (1,7 ↓ ) transmembrane 4 superfamily member 2 -0,29 (1,2 ↓ ) -0,55 (1,5 ↓ ) -0,67 (1,6 ↓ ) -0,38 (1,3 ↓ ) 2510004L01Rik -0,7 (1,6 ↓ ) -1,58 (3,0 ↓ ) -0,07 (1,0 → ) 0,16 (1,1 ↑ ) C81234 -3,12 (8,7 ↓ ) -7,75 (215 ↓ ) -2,29 (4,9 ↓ ) -4,86 (29 ↓ ) Insulin 2 NM -9,89 (948 ↓ ) NM -14,2 (18820 ↓ ) Neurogenin 3 NM NA
    [Show full text]
  • Antigen-Specific Memory CD4 T Cells Coordinated Changes in DNA
    Downloaded from http://www.jimmunol.org/ by guest on September 24, 2021 is online at: average * The Journal of Immunology The Journal of Immunology published online 18 March 2013 from submission to initial decision 4 weeks from acceptance to publication http://www.jimmunol.org/content/early/2013/03/17/jimmun ol.1202267 Coordinated Changes in DNA Methylation in Antigen-Specific Memory CD4 T Cells Shin-ichi Hashimoto, Katsumi Ogoshi, Atsushi Sasaki, Jun Abe, Wei Qu, Yoichiro Nakatani, Budrul Ahsan, Kenshiro Oshima, Francis H. W. Shand, Akio Ametani, Yutaka Suzuki, Shuichi Kaneko, Takashi Wada, Masahira Hattori, Sumio Sugano, Shinichi Morishita and Kouji Matsushima J Immunol Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Author Choice option Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Freely available online through http://www.jimmunol.org/content/suppl/2013/03/18/jimmunol.120226 7.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Author Choice Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 24, 2021. Published March 18, 2013, doi:10.4049/jimmunol.1202267 The Journal of Immunology Coordinated Changes in DNA Methylation in Antigen-Specific Memory CD4 T Cells Shin-ichi Hashimoto,*,†,‡ Katsumi Ogoshi,* Atsushi Sasaki,† Jun Abe,* Wei Qu,† Yoichiro Nakatani,† Budrul Ahsan,x Kenshiro Oshima,† Francis H.
    [Show full text]
  • Views of Distant-Acting G, Gudbjartsson DF, Magnusson KP, Andersen K, Levey AI, Backman Enhancers
    BASIC RESEARCH www.jasn.org A 4.1-Mb Congenic Region of Rf-4 Contributes to Glomerular Permeability † ‡ † Caitlin C. O’Meara,* Michelle M. Lutz, Allison B. Sarkis,* Haiyan Xu,* Rajendra K. Kothinti,§ † † | Matthew Hoffman,* Carol Moreno,* Niloofar M. Tabatabai,§ Jozef Lazar,* † Richard J. Roman,¶ and Howard J. Jacob* ** *Human and Molecular Genetics Center and Departments of †Physiology, ‡Anesthesiology, §Medicine, |Dermatology, and **Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin; and ¶Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi ABSTRACT The combined transfer of two renal function quantitative trait loci (QTLs), Rf-1 (rat chromosome 1) and Rf-4 (rat chromosome 14), from the Fawn-hooded hypertensive rat onto the August Copenhagen Irish genetic background significantly increases proteinuria and demonstrates an interaction between these QTLs. Because the original Rf-4 congenic region is 61.9 Mbp, it is necessary to reduce this interval to feasibly search for variants responsible for renal susceptibility in this region. Here, we generated a minimal con- genic line (Rf-1a+4_a) to identify a 4.1-Mb region of the Rf-4 QTL that significantly contributes to the severity of proteinuria in the Fawn-hooded hypertensive rat. Rf-1a+4_a animals have an increased glo- merular permeability to albumin without significant changes in BP, indicating that at least one genetic element in this refined region directly affects renal function. Sequence analysis revealed no variants pre- dicted to damage protein function, implying that regulatory elements are responsible for the Rf-4 phe- notype. Multiple human studies, including recent genome-wide association studies, link the homologous human region with susceptibility to renal disease, suggesting that this congenic line is an important model for studying pathways that contribute to the progression of kidney disease.
    [Show full text]
  • Nup88 (22): Sc-136009
    SANTA CRUZ BIOTECHNOLOGY, INC. Nup88 (22): sc-136009 BACKGROUND APPLICATIONS The nuclear pore complex (NPC) mediates bidirectional macromolecular Nup88 (22) is recommended for detection of Nup88 of mouse, rat and human traffic between the nucleus and cytoplasm in eukaryotic cells and is com- origin by Western Blotting (starting dilution 1:200, dilution range 1:100- prised of more than 100 different subunits. Many of the subunits belong to 1:1000), immunoprecipitation [1-2 µg per 100-500 µg of total protein (1 ml a family called nucleoporins (Nups), which are characterized by the pres- of cell lysate)] and immunofluorescence (starting dilution 1:50, dilution range ence of O-linked-N-acetylglucosamine moieties and a distinctive pentapep- 1:50-1:500). tide repeat (XFXFG). Nup88 (nucleoporin 88 kDa) is a 741 amino acid protein Suitable for use as control antibody for Nup88 siRNA (h): sc-75980, Nup88 that localizes to the nucleus and functions as an essential component of siRNA (m): sc-75981, Nup88 shRNA Plasmid (h): sc-75980-SH, Nup88 shRNA the nuclear pore complex. Expressed ubiquitously, Nup88 is subject to phos- Plasmid (m): sc-75981-SH, Nup88 shRNA (h) Lentiviral Particles: sc-75980-V phorylation by ATM or ATR and is upregulated in malignant neoplasms and and Nup88 shRNA (m) Lentiviral Particles: sc-75981-V. precancerous dysplasias, suggesting a role in tumorigenesis. The gene encod- ing Nup88 maps to human chromosome 17p13.2, which comprises over 2.5% Molecular Weight of Nup88: 88 kDa. of the human genome and encodes over 1,200 genes. Positive Controls: IMR-32 cell lysate: sc-2409, HeLa whole cell lysate: sc-2200 or A-431 whole cell lysate: sc-2201.
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Supplementary Data Table 1. Genes Upregulated in N-Myc-Overexpressing Mouse Mac1+/Gr1+ BM Cells
    Supplementary Data Table 1. Genes upregulated in N-Myc-overexpressing mouse Mac1+/Gr1+ BM cells Probeset C-myc / N-myc / N-myc / C- Gene Title Representative 430v2 Vector Fold Vector Fold myc Fold Public ID Change Change Change 1435368_a_at 2.3 4.6 2.1 poly (ADP-ribose) polymerase family, member 1 BB767586 1455648_at 1.3 3.0 2.1 similar to reduced expression 2 /// similar to reduced expression 2 BG244780 1438973_x_at 2.5 9.8 4.0 gap junction membrane channel protein alpha 1 BB043407 1419915_at 2.0 3.0 2.1 DNA segment, Chr 10, ERATO Doi 438, expressed AW538011 1454842_a_at 1.6 4.0 2.3 UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, AI853240 polypeptide 2 1436704_x_at 2.1 9.2 3.2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent), AV215673 methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase 1423142_a_at 2.0 2.5 2.1 GTP binding protein 4 AI987834 1420043_s_at 2.5 5.7 2.8 THO complex 1 AW107924 1439444_x_at 1.5 4.3 2.5 transmembrane emp24-like trafficking protein 10 (yeast) /// similar to AV213456 transmembrane trafficking protein 1438610_a_at 1.9 4.9 2.3 Crystallin, zeta BB793369 1434291_a_at 2.5 4.3 2.8 small EDRK-rich factor 1 AA709993 1422716_a_at 2.8 6.5 2.6 acid phosphatase 1, soluble AW554436 1447895_x_at -1.3 2.3 2.6 PAN3 polyA specific ribonuclease subunit homolog (S. cerevisiae) AV368189 1434097_at 1.5 3.2 2.5 Transcribed locus BM218328 1420982_at 1.1 3.5 2.6 RNA-binding region (RNP1, RRM) containing 2 NM_133242 1433853_at 2.6 7.5 2.6 mindbomb homolog 1 (Drosophila) BG063791 1419824_a_at 1.6 4.0 2.1 RIKEN cDNA A230062G08 gene AI875121 1453797_at 7.5 14.9 2.1 phosphatase, orphan 2 AK010147 1440803_x_at 2.3 4.0 2.3 tachykinin receptor 3 BB498416 1455737_at -2.0 1.1 2.8 RIKEN cDNA C030002B11 gene AU040848 1450954_at -1.5 2.8 4.6 YME1-like 1 (S.
    [Show full text]
  • A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M
    Santos and Hartman Cancer & Metabolism (2019) 7:9 https://doi.org/10.1186/s40170-019-0201-3 RESEARCH Open Access A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin Sean M. Santos and John L. Hartman IV* Abstract Background: The influence of the Warburg phenomenon on chemotherapy response is unknown. Saccharomyces cerevisiae mimics the Warburg effect, repressing respiration in the presence of adequate glucose. Yeast phenomic experiments were conducted to assess potential influences of Warburg metabolism on gene-drug interaction underlying the cellular response to doxorubicin. Homologous genes from yeast phenomic and cancer pharmacogenomics data were analyzed to infer evolutionary conservation of gene-drug interaction and predict therapeutic relevance. Methods: Cell proliferation phenotypes (CPPs) of the yeast gene knockout/knockdown library were measured by quantitative high-throughput cell array phenotyping (Q-HTCP), treating with escalating doxorubicin concentrations under conditions of respiratory or glycolytic metabolism. Doxorubicin-gene interaction was quantified by departure of CPPs observed for the doxorubicin-treated mutant strain from that expected based on an interaction model. Recursive expectation-maximization clustering (REMc) and Gene Ontology (GO)-based analyses of interactions identified functional biological modules that differentially buffer or promote doxorubicin cytotoxicity with respect to Warburg metabolism. Yeast phenomic and cancer pharmacogenomics data were integrated to predict differential gene expression causally influencing doxorubicin anti-tumor efficacy. Results: Yeast compromised for genes functioning in chromatin organization, and several other cellular processes are more resistant to doxorubicin under glycolytic conditions. Thus, the Warburg transition appears to alleviate requirements for cellular functions that buffer doxorubicin cytotoxicity in a respiratory context.
    [Show full text]
  • Common Differentially Expressed Genes and Pathways Correlating Both Coronary Artery Disease and Atrial Fibrillation
    EXCLI Journal 2021;20:126-141– ISSN 1611-2156 Received: December 08, 2020, accepted: January 11, 2021, published: January 18, 2021 Supplementary material to: Original article: COMMON DIFFERENTIALLY EXPRESSED GENES AND PATHWAYS CORRELATING BOTH CORONARY ARTERY DISEASE AND ATRIAL FIBRILLATION Youjing Zheng, Jia-Qiang He* Department of Biomedical Sciences and Pathobiology, College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA * Corresponding author: Jia-Qiang He, Department of Biomedical Sciences and Pathobiology, Virginia Tech, Phase II, Room 252B, Blacksburg, VA 24061, USA. Tel: 1-540-231-2032. E-mail: [email protected] https://orcid.org/0000-0002-4825-7046 Youjing Zheng https://orcid.org/0000-0002-0640-5960 Jia-Qiang He http://dx.doi.org/10.17179/excli2020-3262 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). Supplemental Table 1: Abbreviations used in the paper Abbreviation Full name ABCA5 ATP binding cassette subfamily A member 5 ABCB6 ATP binding cassette subfamily B member 6 (Langereis blood group) ABCB9 ATP binding cassette subfamily B member 9 ABCC10 ATP binding cassette subfamily C member 10 ABCC13 ATP binding cassette subfamily C member 13 (pseudogene) ABCC5 ATP binding cassette subfamily C member 5 ABCD3 ATP binding cassette subfamily D member 3 ABCE1 ATP binding cassette subfamily E member 1 ABCG1 ATP binding cassette subfamily G member 1 ABCG4 ATP binding cassette subfamily G member 4 ABHD18 Abhydrolase domain
    [Show full text]
  • Supplementary Data Genbank Or OSE Vs RO NIA Accession Gene Name Symbol FC B-Value H3073C09 11.38 5.62 H3126B09 9.64 6.44 H3073B0
    Supplementary Data GenBank or OSE vs RO NIA accession Gene name Symbol FC B-value H3073C09 11.38 5.62 H3126B09 9.64 6.44 H3073B08 9.62 5.59 AU022767 Exportin 4 Xpo4 9.62 6.64 H3073B09 9.59 6.48 BG063925 Metallothionein 2 Mt2 9.23 18.89 H3064B07 9.21 6.10 H3073D08 8.28 6.10 AU021923 Jagged 1 Jag1 7.89 5.93 H3070D08 7.54 4.58 BG085110 Cysteine-rich protein 1 (intestinal) Crip1 6.23 16.40 BG063004 Lectin, galactose binding, soluble 1 Lgals1 5.95 10.36 BG069712 5.92 2.34 BG076976 Transcribed locus, strongly similar to NP_032521.1 lectin, galactose binding, soluble 1 5.64 8.36 BG062930 DNA segment, Chr 11, Wayne State University 99, expressed D11Wsu99e 5.63 8.76 BG086474 Insulin-like growth factor binding protein 5 Igfbp5 5.50 15.95 H3002d11 5.13 20.77 BG064706 Keratin complex 1, acidic, gene 19 Krt1-19 5.06 9.07 H3007A09 5.05 2.46 H3065F02 4.84 5.43 BG081752 4.81 1.25 H3010E09 4.71 11.90 H3064c11 4.43 1.00 BG069711 Transmembrane 4 superfamily member 9 Tm4sf9 4.29 1.23 BG077072 Actin, beta, cytoplasmic Actb 4.29 3.01 BG079788 Hemoglobin alpha, adult chain 1 Hba-a1 4.26 6.63 BG076798 4.23 0.80 BG074344 Mesothelin Msln 4.22 6.97 C78835 Actin, beta, cytoplasmic Actb 4.16 3.02 BG067531 4.15 1.61 BG073468 Hemoglobin alpha, adult chain 1 Hba-a1 4.10 6.23 H3154H07 4.08 5.38 AW550167 3.95 5.66 H3121B01 3.94 5.94 H3124f12 3.94 5.64 BG073608 Hemoglobin alpha, adult chain 1 Hba-a1 3.84 5.32 BG073617 Hemoglobin alpha, adult chain 1 Hba-a1 3.84 5.75 BG072574 Hemoglobin alpha, adult chain 1 Hba-a1 3.82 5.93 BG072211 Tumor necrosis factor receptor superfamily,
    [Show full text]
  • Supplementary Table 2
    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
    [Show full text]